Abstract
It has been estimated that over 3 million Americans currently have Graves’ disease of whom over 41,000 are children (1). Graves’ disease is associated with considerable morbidity, a decrease in quality of life and sufferers incur considerable health care costs. Yet the disease has been neglected by epidemiologists and as a result relatively little is known about its prevalence in the population and its social or biological antecedents.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Jacobson DL, Gange SJ, Rose NR, Graham NMH. 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 84:223–243.
Furszyfer J, Kurland LT, McConahey WM, Elveback LR. 1970 Graves’ disease in Olmsted county, Minnesota. 1935 through 1967. Mayo Clin Proc. 45:636–644.
Cox SP, Phillips DIW, Osmond C. 1989 Does infection initiate Graves disease?: a population based 10 year study. Autoimmunity. 4:43–49.
Phillips DIW, Barker DJP, Rees Smith B, Didcote S, Morgan D. 1985 The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies. Clin Endocrinol. 23:283–287.
Thjodleifsson B. 1975 A study of Graves’ disease in Iceland. Acta Med Scand. 198:309–314.
Berglund J, Christensen SB, Hallengren B. 1990 Total and age-specific incidence of Graves’ thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970–74. J Int Med. 227:137–141.
Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. 1991 High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves’ disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Lab Clin Med. 229:415–420.
Haraldsson A, Gudmundsson ST, Larusson G, Sigurdsson G. 1985 Thyrotoxicosis in Iceland 1980–1982. Acta Med Scand. 217:253–258.
Brownlie BEW, Wells JE. 1990 The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in North Canterbury. Clin Endocrinol. 33:249–259.
Westphal SA. 1994 Seasonal variation in the diagnosis of Graves’ disease. Clin Endocrinol. 41:27–30.
Phillips DIW, Barker DJP, Morris JA. 1985 Seasonality of thyrotoxicosis. J Epidem Commun Health. 39:72–74.
Phillips DIW. 1997 Iodine, milk and the elimination of endemic goitre:the story of an accidental public health triumph. J Epidem Commun Health. 51:391–393.
Iversen K. 1948 Temporary rise in the frequency of thyrotoxicosis in Denmark. Copenhagen: Rosenkilde & Bagger.
Trowell HC. Non-infective disease in Africa. 1960 London: Edward Arnold, p286
Kalk WJ. 1981 Thyrotoxicosis in urban black Africans: a rising incidence. S Afr J Med. 52:109–116.
Bartley GB, Fatourechi V, Kadrmas EF, et al. 1995 The incidence of Graves’ ophthalmopathy in Olmsted County, Minnesota. Amer J Ophthal. 120:511–517.
Tellez M, Cooper J, Edmonds C. 1992 Graves’ Ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol. 36:291–294.
Hagg E, Asplund K. 1987 Is endocrine ophthalmopathy related to smoking? Brit Med J. 295:634–635.
Bartalena L, Bogazzi F, Tanda ML, Manetti L, Dell’Unto E, Martino E. 1995 Cigarette smoking and the thyroid. Eur J Endocrinol. 133:507–512.
Shine B, Fells P, Edwards OM, Weetman AP. 1990 Association between Graves’ ophthalmopathy and smoking. Lancet. 335:1261–1263.
Winsa B, Mandahl A, Karlsson FA. 1993 Graves’ disease, endocrine ophthalmopathy and smoking. Acta Endocrinol (Copenh). 128:156–160.
Prummel MF, Wiersinga WM. 1993 Smoking and risk of Graves’ disease. JAMA. 269:479–482.
Yoshiuchi K, Kumano H, Nomura S, et al. 1998 Stressful life events and smoking were associated with Graves’ disease in women, but not in men. Psychosom Med. 60:182–185.
Caleb Hillier Parry. 1932 Hyperthyroidism. In: Major RH, ed. Classic descriptions of disease. Oxford: Blackwell, pp 275–279.
Hobbs JR. 1992 Stress and Graves’ disease. Lancet. 339:427–428.
Gray J, Hoffenberg R. 1985 Thyrotoxicosis and stress. Q J Med. 54:153–160.
Winsa B, Adami HO, Bergstrom R, et al. 1991 Stressful life events and Graves’ disease. Lancet. 338:1475–1479.
Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA. 1993 Life events in the pathogenesis of Graves’ disease. A controlled study. Acta Endocrinol (Copenh). 128:293–296.
Kung A.W. 1995 Life events, daily stresses and coping in patients with Graves’ disease. Clin Endocrinol. 42:303–308.
Harris T, Creed F, Brugha TS. 1992 Stressful life events and Graves’ disease. Br J Psychiatry. 161:535–541.
Gripenberg M, Miettinen A, Kurki P, Linder E. 1978 Indirect immunofluorescence and anti-epithelial antibodies in Yersinial infections. Arthritis Rheum. 21:904–908.
Shenkman L, Bottone EJ. 1976 Antibodies to Yersinia enterocolitica in thyroid disease. Ann Int Med. 85:735–739.
Keddie N, Metcalfe-Gibson C, Tooth JA. 1977 Yersinia and thyroid disease. Lancet. (ii):1368
Weetman AP, McGregor AM. 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev. 15:788–830.
Barker DJP, Phillips DIW. 1984 Current incidence of hyperthyroidism and past prevalence of endemic goitre in 12 British towns. Lancet. (ii):567–570.
Safran M, Paul TL, Roti E, Braverman LE. 1987 Environmental factors affecting autoimmune thyroid disease. Endocrinol Metab Clin N Amer. 16:327–342.
Mostbeck A, Galvan G, Bauer P, et al. 1998 The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med. 25:367–374.
Hancock SL, Cox RS, McDougall IR. 1991 Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med. 325:599–605.
Phillips DIW. 1985 The Epidemiology of hyperthyroidism in England and Wales. PhD Thesis, University of Southampton pp 51–52.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Phillips, D. (2000). Epidemiology of Graves’ Disease. In: Rapoport, B., McLachlan, S.M. (eds) Graves’ Disease. Endocrine Updates, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4407-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4407-4_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6983-7
Online ISBN: 978-1-4615-4407-4
eBook Packages: Springer Book Archive